Equities

BIO-Key International Inc

BJO0:BER

BIO-Key International Inc

Actions
  • Price (EUR)2.59
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-69.23%
  • Beta--
Data delayed at least 15 minutes, as of Dec 20 2023 20:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year BIO-Key International Inc grew revenues 10.46% from 7.02m to 7.75m while net income improved from a loss of 11.91m to a smaller loss of 8.52m.
Gross margin9.99%
Net profit margin-148.20%
Operating margin-155.86%
Return on assets-116.86%
Return on equity-644.57%
Return on investment-509.01%
More ▼

Cash flow in USDView more

In 2023, cash reserves at BIO-Key International Inc fell by 2.12m. Cash Flow from Financing totalled 1.43m or 18.48% of revenues. In addition the company used 3.79m for operations while cash used for investing totalled 1.00k.
Cash flow per share-7.57
Price/Cash flow per share--
Book value per share-0.5818
Tangible book value per share-1.27
More ▼

Balance sheet in USDView more

BIO-Key International Inc has a Debt to Total Capital ratio of 187.73%, a higher figure than the previous year's 6.64%.
Current ratio0.5408
Quick ratio0.463
Total debt/total equity--
Total debt/total capital1.88
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.